Expression of KAI1/CD82 in laryngeal squamous cell carcinoma and laryngeal squamous intraepithelial neoplasia and its clinical significance

Meng Liping,Huang Zhichun
DOI: https://doi.org/10.16016/j.1000-5404.2010.22.040
2010-01-01
Abstract:Objective To explore the clinical significance of the expression of KAI1/CD82 in the tissues of laryngeal squamous cell carcinoma (LSCC), laryngeal squamous intraepithelial neoplasia (SIN) Ⅰ to Ⅲ and normal laryngeal mucosa. Methods Envision immunohistochemistry was used to detect the expression of KAI1/CD82 gene in 26 specimens of LSCC, 34 specimens of laryngeal SIN Ⅰ to Ⅲ, and 10 specimens of normal laryngeal mucosa. Correlation of the expression of KAI1/CD82 gene to clinicopathologic data were statistically analyzed. Results The rates of negative, weak, moderate, and strong expression of KAI1/CD82 in LSCC were 57.7% (15/26), 26.9% (7/26), 15.4%(4/26), and 0%(0/26), respectively, significantly lower than those in normal laryngeal mucosa and laryngeal SIN (P=0.000 5). Expression of KAI1/CD82 in LSCC had no correlation with clinical stage, tumor histological grade and lymph node metastasis (P>0.05). There was no correlation between the expression of KAI1/CD82 in laryngeal SINⅠ~Ⅲ and histological grade (P>0.05) . Conclusion The change of KAI1/CD82 expression is an early event in tumorigenesis of LSCC. KAI1/CD82 may play a significant role from laryngeal SIN to LSCC. Its down-regulation may be considered as a potential marker for tumor metastasis.
What problem does this paper attempt to address?